Alpha 2.0
Login Register
» Authors » Rebekah Street

Rebekah Street

Explore the profile of Rebekah Street including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 28
Followers 0
Related Specialties
Psychiatry
Neurology
Public Health
Top 10 Co-Authors
G Paul Amminger
Barnaby Nelson
Patrick D McGorry
Andrew Thompson
Andrea Polari
Amelia L Quinn
Maximus Berger
Hok Pan Yuen
Natalie Ferguson
Eric Y H Chen
Published In
Aust N Z J Psychiatry
Schizophr Res
BJPsych Open
JAMA Psychiatry
Ir J Psychol Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Prevalence of depressive symptoms, suicidal ideation and behaviours in young people presenting with a first episode of psychosis
FitzPatrick P, Brown E, Street R, ODonoghue B
Ir J Psychol Med . 2024 Dec; :1-7. PMID: 39639528
Objectives: Suicide accounts for a proportion of the early mortality in people affected by psychotic disorders. The early phase of illness can represent a particularly high-risk time for suicide. Therefore,...
2.
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
Moller P, Nelson B, McGorry P, Mei C, Amminger G, Yuen H, et al.
Schizophr Bull . 2024 Sep; PMID: 39241740
Background: Since the late 1990s, there has been a worldwide surge of scientific interest in the pre-psychotic phase, resulting in the introduction of several clinical tools for early detection. The...
3.
Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis
Collins M, Bartholomeusz C, Mei C, Kerr M, Spark J, Wallis N, et al.
Psychiatry Res . 2024 May; 337:115966. PMID: 38810536
Decreased white matter (WM) integrity and disturbance in fatty acid composition have been reported in individuals at ultra-high risk of psychosis (UHR). The current study is the first to investigate...
4.
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized Trial
McGorry P, Mei C, Amminger G, Yuen H, Kerr M, Spark J, et al.
JAMA Psychiatry . 2023 Jun; 80(9):875-885. PMID: 37378974
Importance: Clinical trials have not established the optimal type, sequence, and duration of interventions for people at ultrahigh risk of psychosis. Objective: To determine the effectiveness of a sequential and...
5.
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
Amminger G, Rice S, Davey C, Quinn A, Hermens D, Zmicerevska N, et al.
Biol Psychiatry . 2023 Jun; 95(5):426-433. PMID: 37355004
Background: Clinical trials suggest that long-chain omega-3 polyunsaturated fatty acids (n-3 PUFAs) (fish oil) may reduce depressive symptoms in adults with major depressive disorder. Therefore, n-3 PUFAs may be a...
6.
The promise of the therapeutic use of cannabidiol for psychiatric disorders
Amminger G, Street R, Davey C, Lin A
Aust N Z J Psychiatry . 2023 May; 57(10):1301-1303. PMID: 37166111
No abstract available.
7.
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis
Susai S, Healy C, Mongan D, Heurich M, Byrne J, Cannon M, et al.
Transl Psychiatry . 2022 Oct; 12(1):454. PMID: 36307392
Preliminary evidence indicates beneficial effects of omega-3 polyunsaturated fatty acids (PUFAs) in early psychosis. The present study investigates the molecular mechanism of omega-3 PUFA-associated therapeutic effects in clinical high-risk (CHR)...
8.
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
Cheng N, McLaverty A, Nelson B, Markulev C, Schafer M, Berger M, et al.
BJPsych Open . 2022 Sep; 8(5):e165. PMID: 36073014
Background: Cognitive impairments are well-established features of psychotic disorders and are present when individuals are at ultra-high risk for psychosis. However, few interventions target cognitive functioning in this population. Aims:...
9.
Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial
Susai S, Mongan D, Healy C, Cannon M, Cagney G, Wynne K, et al.
Brain Behav Immun . 2022 Mar; 103:50-60. PMID: 35341915
Background: Functional outcomes are important measures in the overall clinical course of psychosis and individuals at clinical high-risk (CHR), however, prediction of functional outcome remains difficult based on clinical information...
10.
The incidence and admission rate for first-episode psychosis in young people before and during the COVID-19 pandemic in Melbourne, Australia
ODonoghue B, Collett H, Boyd S, Zhou Y, Castagnini E, Brown E, et al.
Aust N Z J Psychiatry . 2021 Oct; 56(7):811-817. PMID: 34651504
Objective: The COVID-19 pandemic has had a profound effect on global mental health, with one-third of infected individuals developing a psychiatric or neurological disorder 6 months after infection. The risk...